造影剤注入器市場：セグメント別規模、シェア、法規制、償還、設置ベース、2033年までの予測

造影剤注入器は、手動、自動、シリンジレス、デュアルヘッド、シングルヘッドに分類できます。造影剤注入器は、血管のような体内の画像化しにくい構造を明確にするために造影剤を供給することによって、様々なCTやMRIスキャン手順における画質を向上させるための重要な装置です。

造影剤注入器市場は、世界の高齢化と慢性疾患の増加により成長を遂げているMRIやCTスキャナーなどの画像診断システムの売上が牽引しています。造影剤注入器の市場規模は、世界的に安定した成長を遂げており、中国やインドのような医療分野が活況を呈している新興国で高い成長を遂げています。

当レポートは、世界の造影剤注入器市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている造影剤注入器と競合情勢

• 主要な業界動向の洞察
• 造影剤注入器のセグメント別総市場収益と2015年～2033年の市場展望
• 台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 造影剤注入器市場のSWOT分析
• 造影剤注入器市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Contrast Media Injectors Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.

The model discusses in detail the impact of COVID-19 on Contrast Media Injectors market for the year 2020 and beyond. Contrast media injectors can be categorized as manual, automatic, syringeless, dual or single headed. Contrast media injectors are the key devices for improving image quality in various CT and MRI scanning procedures by delivering the contrast media to clarify hard to image structures within the body such as blood vessels.

The market for contrast media injectors is driven by sales of diagnostic imaging systems such as MRI and CT scanners, which have been experiencing growth due to aging global populations and the rising prevalence of chronic diseases. The market for contrast media injectors is experiencing stable growth globally and high growth in emerging economies like China and India whose health sectors are booming.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Contrast Media Injectors and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Contrast Media Injectors market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Contrast Media Injectors market.
• Competitive dynamics insights and trends provided for Contrast Media Injectors market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Imaxeon Pty Ltd, Nemoto Kyorindo Co Ltd, Guerbet SA, Bracco Imaging SpA, Ulrich GmbH & Co KG, Sino Medical-Device Technology Co., Ltd. and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Contrast Media Injectors marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Contrast Media Injectors market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Contrast Media Injectors market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Contrast Media Injectors market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Contrast Media Injectors market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable